Simultaneous Pharmacologic Inhibition of Yes‐Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic‐co‐Glycolic) Acid–Encapsulated Microparticles Improves Pulmonary Hypertension is a research paper published in Journal of the American Heart Association (2021). On theSindex it has a DataRank of 0.553. It has been cited 39 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.553
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 4UH3TR002073-03
Computational repurposing of chemotherapies for pulmonary hypertension
National Institutes of Health
Grant: 5R01HL138437-04
Molecular Drivers of Vascular Stiffness and Metabolic Dysfunction in HIV-Induced Pulmonary Arterial Hypertension
National Institutes of Health
Grant: 5R01HL122596-04
Iron-Sulfur Deficiency as a Critical Pathogenic Cause of Pulmonary Hypertension
French National Research Agency (ANR)
Grant: ANR-20-CE14-0006
To capitalize on activated adventitial fibroblasts metabolism to treat pulmonary hypertension
French National Research Agency (ANR)
Grant: ANR-18-CE14-0025
Understanding the dynamic of the vascular niche in pulmonary hypertension (PH). Matrix reprogramming forces PH.
National Institutes of Health
Grant: 5R01HL124021-09
An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH
Fields of Study
Keywords
Sustainable Development Goals